fashion -WSS

fashion

author：explore 2025-10-01 17:57:20 - browse：27

A drug developed by the biotech firm BridgeBio to treat an increasingly common heart condition succeeded in its main goal in a clinical trial, the company said Monday, and also pointed to potential reductions in hospitalization and death.

The results may give the medicine, acoramidis, a path to the market after a failure that led its maker’s stock to plunge in December 2021.

In the time since the initial failure, a rival Pfizer drug has become even more entrenched and another medicine, from Alnylam Pharmaceuticals, has had a successful clinical readout in the heart disease, known as ATTR-CM, in which a defective protein leads clumps to build up in the heart.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Novavax promises a turnaround & Lilly roils the obesity market
Next article： WHO recommends dropping component of many flu vaccines

entertainment

Wikipedia

WSS

How one patient went off dialysis — and others can too

Rikers Island jail violence not addressed, NYC should be held in contempt: Fed monitor

ACA's risk program benefits Blue Cross Blue Shield insurers

‘Insidious 5’ topples 'Indiana Jones' before ‘Mission: Impossible’ launches

Biden targets hefty hospital 'facility fees' that often surprise patients

Biden’s NIH nominee is languishing in Congress

leisure time

fashion

leisure time

Walensky prepares to leave CDC — and Congress — behind

STAT Virtual Event: How to Increase Diversity in Clinical Trials

Trump demands the U.S. pay no more for drugs than other countries … again

Accuser who called Kevin Spacey 'vile sexual predator' admits he joked about incident

Novavax promises a turnaround & Lilly roils the obesity market

See Ryan Reynolds, Hugh Jackman suited up in 1st look at 'Deadpool 3': Photo

What does generative AI mean for health care? We asked experts

Eisai exec who led development of Alzheimer’s drug to retire

Alkermes shareholders re

Paxlovid should be available without a positive Covid test

focus

Presidential fundraising highlights so far: Trump brings in more than DeSantis

Sudafed saga points to U.S. issues with evaluating older drugs

WHO recommends dropping component of many flu vaccines

ACA's risk program benefits Blue Cross Blue Shield insurers

Sudafed saga points to U.S. issues with evaluating older drugs

FDA advisers vote against ALS treatment from BrainStorm

entertainment

Wikipedia

Wikipedia

knowledge